Novo Nordisk The stock has lost 50% of its value in the last year due to a combination of factors: In Q1 2025, U.S
Think of them like the bodys messengers, deploying molecules where theyre needed most, supporting immune function, physical growth, blood oxygenation, metabolism, muscle contraction, sexual function and more
It is especially beneficial for older adults, pregnant women, and those at higher risk of severe illness
This triple mechanism distinguishes it from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 agonist)
Roque Eye Clinic Patient Education Series Reviewed by the Roque Advisory Council Dr Manolette Roque | Dr Barbara Roque St Lukes Medical Center Global City | Asian Hospital Medical Center Philippines Medical Review: Roque Advisory Council Last Updated: March 2026 This article is intended for educational purposes only and does not replace professional medical consultation.